Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230825059254N1Phase 3Completed
Phase 3, single-blind trial of thiopental (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Depth of anesthesia, Heart rate and 1 more. Started Oct 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230825059254N1.